植入前非整倍体遗传学检测对年轻复发性种植失败女性活产率的影响:一项多中心随机试验的二次分析
该研究为多中心随机双盲安慰剂对照试验的二次分析,纳入中国8家生殖中心2018至2020年485例年龄<38岁、有≥2次胚胎移植失败史且累计移植≥3枚优质胚胎的复发性种植失败女性,比较单囊胚移植±PGT-A的活产率。结果显示PGT-A组与非PGT-A组活产率在倾向评分匹配前后均无显著差异,未校正和校正后logistic回归均未显示PGT-A获益,母儿并发症发生率亦无显著差异。结论认为年龄<38岁复发性种植失败患者不能从PGT-A获益。
要点
- 年龄<38岁复发性种植失败女性中,PGT-A组与非PGT-A组每次移植活产率无显著差异。
- 倾向评分匹配前后及多因素校正后,PGT-A均未显示对活产率的获益。
- 两组母儿并发症发生率无显著差异。
核心结论
- 年龄<38岁的复发性种植失败患者不能从PGT-A获益,遗传异常以外的因素可能参与这一临床难题。
研究设计与样本
- 多中心、随机、双盲、安慰剂对照临床试验的二次分析,在中国8家学术型生殖中心于2018至2020年开展。
- 共评估485例年龄<38岁的不孕女性,均有≥2次胚胎移植失败史且累计移植≥3枚优质胚胎,接受单囊胚移植伴或不伴PGT-A。
- 排除薄型子宫内膜或复发性妊娠丢失者,患者分为PGT-A组和非PGT-A组,所有妊娠随访至分娩。
- 采用倾向评分匹配和多因素logistic回归模型校正潜在混杂因素,主要结局为每次胚胎移植的活产率。
主要发现
- PGT-A组与非PGT-A组活产率在倾向评分匹配前为39.1% vs 41.5%(p=0.760),匹配后为39.1% vs 40.6%(p=0.862),均无显著差异。
- 未校正logistic回归显示PGT-A对每次移植活产率无获益(粗OR 0.91,95%CI 0.49-1.69),校正后亦无获益(校正OR 1.04,95%CI 0.53-2.03)。
- 两组母儿并发症发生率无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the benefit of preimplantation genetic testing for aneuploidy (PGT-A) in recurrent implantation failure (RIF). DESIGN: Secondary analysis of a multicentre, randomised, double-blind, placebo-controlled clinical trial. SETTING: Eight academic fertility centres in China, 2018-2020. POPULATION: Overall, 485 infertile women aged < 38 years were evaluated. They had a history of two or more unsuccessful embryo transfer cycles with at least three good-quality embryos that had been transferred cumulatively and underwent a single blastocyst transfer with or without PGT-A. Those with thin endometrium or recurrent pregnancy loss were excluded. METHODS: Patients were categorised into PGT-A and non-PGT-A groups. All pregnancies were followed to delivery. Pregnancy and neonatal outcomes were obtained from obstetric and neonatal medical records. Propensity score matching (PSM) and multivariate logistic regression models were applied to adjust for potential confounding factors. MAIN OUTCOME MEASURES: LBR per embryo transfer. RESULT(S): There was no significant difference in LBR between the PGT-A and non-PGT-A groups both before (39.1% vs. 41.5%, p = 0.760) and after (39.1% vs. 40.6%, p = 0.862) PSM. Unadjusted and adjusted logistic regression models revealed no beneficial effect of PGT-A on LBR per embryo transfer (crude odds ratio: 0.91, 95% confidence interval: 0.49-1.69; adjusted odds ratio: 1.04, 95% confidence interval: 0.53-2.03). The incidence of maternal and neonatal complications was not significantly different between the groups. CONCLUSIONS: Patients with RIF aged < 38 years do not benefit from PGT-A. Thus, factors other than genetic abnormalities may contribute to this clinical conundrum.
引用
- Guan H, He Y, Lu Y, et al. Effect of Preimplantation Genetic Testing for Aneuploidy on Live Birth Rate in Young Women With Recurrent Implantation Failure: A Secondary Analysis of a Multicentre Randomised Trial. BJOG. 2024. PMID: 39679713. doi:10.1111/1471-0528.18027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。